TrialClinical rheumatology2023

Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Cindy L J Weinstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.